Share Price and Basic Stock Data
Last Updated: January 19, 2026, 8:20 pm
| PEG Ratio | -23.13 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
AksharChem (India) Ltd operates in the Dyes & Pigments industry, with its stock price currently standing at ₹227 and a market capitalization of ₹183 Cr. The company’s revenue has shown fluctuations, with sales reported at ₹90.52 Cr in September 2022, declining to ₹64.91 Cr by December 2022, then rebounding slightly to ₹71.68 Cr in June 2023. As of September 2023, sales rose to ₹73.30 Cr, and projections indicate a gradual increase to ₹90.69 Cr by December 2024. Despite these fluctuations, the company’s trailing twelve months (TTM) sales stood at ₹368 Cr, indicating a recovery trajectory compared to the previous year’s ₹335 Cr. However, the volatility in sales raises concerns about operational stability and market demand dynamics. The company’s ability to maintain revenue growth amidst industry challenges will be critical for its long-term performance.
Profitability and Efficiency Metrics
AksharChem’s profitability metrics reveal a challenging landscape, with an operating profit margin (OPM) of just 2.63%, reflecting the company’s struggle to convert sales into profit effectively. The operating profit reported varied significantly, with a peak of ₹5.50 Cr in September 2022, dropping to a negative ₹5.38 Cr by June 2023, before recovering to ₹4.94 Cr in December 2023. The return on equity (ROE) stood at 1.82%, while the return on capital employed (ROCE) was at 3.46%, indicating suboptimal efficiency in utilizing capital to generate profits. The interest coverage ratio (ICR) was relatively strong at 10.02x, suggesting that the company is comfortably managing its interest obligations. However, the volatility in net profits, with a significant decline to -₹7.60 Cr in September 2023, followed by a small recovery to ₹0.33 Cr in December 2023, highlights the need for improved operational efficiency and cost management strategies.
Balance Sheet Strength and Financial Ratios
AksharChem’s balance sheet reflects a mix of strengths and weaknesses. The company reported total reserves of ₹254 Cr against borrowings of ₹75 Cr, indicating a healthy reserve position relative to debt levels. The debt-to-equity ratio remains manageable, suggesting prudent financial management. However, the company’s price-to-book value (P/BV) stands at 1.41x, which is relatively high compared to industry norms, indicating potential overvaluation. The cash conversion cycle (CCC) was reported at 67 days, suggesting that the company takes a considerable time to convert its investments into cash flows, which may impact liquidity. Additionally, the return on capital employed (ROCE) at 3% indicates that the company is not generating sufficient returns on its capital investments, which could deter potential investors. This combination of factors necessitates a closer examination of operational strategies to enhance financial stability.
Shareholding Pattern and Investor Confidence
The shareholding pattern of AksharChem indicates a strong promoter presence, holding 62.70% of the equity, which can be seen as a stabilizing factor for the company. Institutional ownership, however, is minimal, with foreign institutional investors (FIIs) holding only 0.02% and domestic institutional investors (DIIs) at 0.06%. This lack of institutional backing may reflect investor caution regarding the company’s profitability and operational performance. The number of shareholders has declined from 15,722 in December 2022 to 13,139 as of September 2025, suggesting a potential loss of investor confidence. The public shareholding stood at 37.22%, indicating a relatively low level of retail investor participation, which may limit liquidity in trading. A higher promoter stake can be beneficial, but the lack of institutional support raises questions about the company’s attractiveness to broader market participants.
Outlook, Risks, and Final Insight
Looking ahead, AksharChem faces a challenging environment with both strengths and risks. On the positive side, the company’s strong promoter backing and manageable debt levels could provide stability during periods of volatility. However, the significant fluctuations in sales and net profits suggest ongoing operational challenges that need to be addressed to restore investor confidence. The potential for revenue growth exists if the company can effectively manage costs and improve operational efficiency. Risks include dependence on market conditions for demand in the dyes and pigments sector and potential liquidity constraints due to the lengthy cash conversion cycle. Overall, while there are opportunities for recovery and growth, the company must navigate its operational challenges effectively to enhance profitability and investor sentiment in the highly competitive landscape of the Dyes & Pigments industry.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Dynamic Industries Ltd | 33.3 Cr. | 110 | 190/68.5 | 18.3 | 162 | 0.91 % | 5.68 % | 3.39 % | 10.0 |
| Daikaffil Chemicals India Ltd | 38.9 Cr. | 64.9 | 242/64.9 | 13.2 | 0.00 % | 18.6 % | 18.6 % | 10.0 | |
| Amal Ltd | 638 Cr. | 516 | 1,148/490 | 23.4 | 91.7 | 0.19 % | 36.3 % | 35.0 % | 10.0 |
| Vidhi Specialty Food Ingredients Ltd | 1,629 Cr. | 329 | 570/272 | 33.8 | 62.2 | 1.52 % | 18.7 % | 14.9 % | 1.00 |
| Ushanti Colour Chem Ltd | 53.9 Cr. | 48.0 | 67.1/38.0 | 37.7 | 0.00 % | 0.98 % | 5.98 % | 10.0 | |
| Industry Average | 1,212.85 Cr | 269.18 | 86.99 | 186.93 | 0.42% | 11.00% | 9.10% | 8.13 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 90.52 | 64.91 | 64.74 | 71.68 | 73.30 | 75.28 | 81.79 | 85.91 | 78.93 | 90.69 | 90.74 | 96.96 | 89.30 |
| Expenses | 85.02 | 62.91 | 63.05 | 72.35 | 76.50 | 70.34 | 81.36 | 79.67 | 72.91 | 84.37 | 84.47 | 90.55 | 86.95 |
| Operating Profit | 5.50 | 2.00 | 1.69 | -0.67 | -3.20 | 4.94 | 0.43 | 6.24 | 6.02 | 6.32 | 6.27 | 6.41 | 2.35 |
| OPM % | 6.08% | 3.08% | 2.61% | -0.93% | -4.37% | 6.56% | 0.53% | 7.26% | 7.63% | 6.97% | 6.91% | 6.61% | 2.63% |
| Other Income | 0.01 | 0.02 | 0.07 | 0.04 | 0.02 | 0.28 | 0.10 | 0.06 | 0.22 | 0.07 | -0.09 | 0.04 | 1.73 |
| Interest | 0.82 | 0.74 | 0.67 | 0.80 | 0.88 | 0.98 | 1.07 | 1.25 | 1.32 | 1.34 | 1.36 | 1.43 | 1.38 |
| Depreciation | 3.24 | 3.24 | 3.17 | 3.35 | 3.49 | 3.47 | 3.47 | 3.46 | 3.51 | 3.51 | 3.52 | 3.99 | 4.11 |
| Profit before tax | 1.45 | -1.96 | -2.08 | -4.78 | -7.55 | 0.77 | -4.01 | 1.59 | 1.41 | 1.54 | 1.30 | 1.03 | -1.41 |
| Tax % | 31.72% | -27.55% | -5.77% | 12.55% | 0.79% | 57.14% | 50.37% | 27.67% | 26.24% | 22.08% | -6.92% | 31.07% | -2.84% |
| Net Profit | 0.98 | -1.42 | -1.97 | -5.38 | -7.60 | 0.33 | -6.02 | 1.15 | 1.04 | 1.19 | 1.39 | 0.71 | -1.37 |
| EPS in Rs | 1.22 | -1.77 | -2.45 | -6.70 | -9.46 | 0.41 | -7.49 | 1.43 | 1.29 | 1.48 | 1.73 | 0.88 | -1.71 |
Last Updated: January 2, 2026, 2:03 pm
Below is a detailed analysis of the quarterly data for AksharChem (India) Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 89.30 Cr.. The value appears to be declining and may need further review. It has decreased from 96.96 Cr. (Jun 2025) to 89.30 Cr., marking a decrease of 7.66 Cr..
- For Expenses, as of Sep 2025, the value is 86.95 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 90.55 Cr. (Jun 2025) to 86.95 Cr., marking a decrease of 3.60 Cr..
- For Operating Profit, as of Sep 2025, the value is 2.35 Cr.. The value appears to be declining and may need further review. It has decreased from 6.41 Cr. (Jun 2025) to 2.35 Cr., marking a decrease of 4.06 Cr..
- For OPM %, as of Sep 2025, the value is 2.63%. The value appears to be declining and may need further review. It has decreased from 6.61% (Jun 2025) to 2.63%, marking a decrease of 3.98%.
- For Other Income, as of Sep 2025, the value is 1.73 Cr.. The value appears strong and on an upward trend. It has increased from 0.04 Cr. (Jun 2025) to 1.73 Cr., marking an increase of 1.69 Cr..
- For Interest, as of Sep 2025, the value is 1.38 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 1.43 Cr. (Jun 2025) to 1.38 Cr., marking a decrease of 0.05 Cr..
- For Depreciation, as of Sep 2025, the value is 4.11 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3.99 Cr. (Jun 2025) to 4.11 Cr., marking an increase of 0.12 Cr..
- For Profit before tax, as of Sep 2025, the value is -1.41 Cr.. The value appears to be declining and may need further review. It has decreased from 1.03 Cr. (Jun 2025) to -1.41 Cr., marking a decrease of 2.44 Cr..
- For Tax %, as of Sep 2025, the value is -2.84%. The value appears to be improving (decreasing) as expected. It has decreased from 31.07% (Jun 2025) to -2.84%, marking a decrease of 33.91%.
- For Net Profit, as of Sep 2025, the value is -1.37 Cr.. The value appears to be declining and may need further review. It has decreased from 0.71 Cr. (Jun 2025) to -1.37 Cr., marking a decrease of 2.08 Cr..
- For EPS in Rs, as of Sep 2025, the value is -1.71. The value appears to be declining and may need further review. It has decreased from 0.88 (Jun 2025) to -1.71, marking a decrease of 2.59.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:41 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 145 | 200 | 188 | 248 | 264 | 323 | 260 | 246 | 380 | 335 | 302 | 346 | 368 |
| Expenses | 112 | 172 | 155 | 171 | 223 | 288 | 234 | 223 | 349 | 319 | 301 | 321 | 346 |
| Operating Profit | 33 | 27 | 32 | 78 | 42 | 34 | 26 | 24 | 32 | 15 | 2 | 25 | 21 |
| OPM % | 23% | 14% | 17% | 31% | 16% | 11% | 10% | 10% | 8% | 5% | 0% | 7% | 6% |
| Other Income | -2 | 3 | 1 | 9 | 7 | 5 | 1 | 1 | 1 | 0 | 0 | 0 | 2 |
| Interest | 1 | 3 | 3 | 3 | 1 | 1 | 1 | 1 | 2 | 3 | 4 | 5 | 6 |
| Depreciation | 1 | 4 | 4 | 5 | 5 | 6 | 7 | 7 | 12 | 13 | 14 | 14 | 15 |
| Profit before tax | 29 | 24 | 26 | 79 | 43 | 33 | 19 | 17 | 18 | -0 | -16 | 6 | 2 |
| Tax % | 31% | 32% | 36% | 33% | 28% | 32% | 18% | 28% | 11% | 88% | 20% | 18% | |
| Net Profit | 20 | 16 | 17 | 53 | 31 | 23 | 16 | 12 | 16 | -1 | -19 | 5 | 2 |
| EPS in Rs | 40.46 | 21.88 | 22.75 | 72.37 | 37.26 | 27.54 | 19.16 | 15.24 | 19.81 | -1.17 | -23.25 | 5.94 | 2.38 |
| Dividend Payout % | 12% | 16% | 15% | 5% | 9% | 13% | 18% | 23% | 3% | -43% | -2% | 13% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -20.00% | 6.25% | 211.76% | -41.51% | -25.81% | -30.43% | -25.00% | 33.33% | -106.25% | -1800.00% | 126.32% |
| Change in YoY Net Profit Growth (%) | 0.00% | 26.25% | 205.51% | -253.27% | 15.70% | -4.63% | 5.43% | 58.33% | -139.58% | -1693.75% | 1926.32% |
AksharChem (India) Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 6% |
| 3 Years: | -3% |
| TTM: | 13% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | -10% |
| 5 Years: | -21% |
| 3 Years: | -33% |
| TTM: | 136% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 9% |
| 5 Years: | 3% |
| 3 Years: | -9% |
| 1 Year: | -22% |
| Return on Equity | |
|---|---|
| 10 Years: | 6% |
| 5 Years: | 1% |
| 3 Years: | -2% |
| Last Year: | 2% |
Last Updated: September 4, 2025, 10:40 pm
Balance Sheet
Last Updated: December 4, 2025, 12:55 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 5 | 7 | 7 | 7 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 | 8 |
| Reserves | 29 | 64 | 78 | 133 | 230 | 249 | 257 | 271 | 272 | 270 | 251 | 256 | 254 |
| Borrowings | 9 | 24 | 31 | 32 | 0 | 12 | 13 | 15 | 50 | 25 | 52 | 67 | 75 |
| Other Liabilities | 27 | 51 | 39 | 47 | 61 | 47 | 45 | 62 | 76 | 62 | 70 | 85 | 90 |
| Total Liabilities | 70 | 146 | 155 | 219 | 299 | 316 | 323 | 356 | 406 | 365 | 380 | 415 | 427 |
| Fixed Assets | 21 | 55 | 56 | 65 | 86 | 126 | 128 | 229 | 231 | 225 | 235 | 232 | 269 |
| CWIP | 0 | 2 | 4 | 9 | 26 | 31 | 62 | 6 | 16 | 17 | 11 | 45 | 15 |
| Investments | 8 | 18 | 22 | 51 | 77 | 21 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 41 | 71 | 72 | 94 | 110 | 138 | 131 | 120 | 159 | 122 | 135 | 139 | 144 |
| Total Assets | 70 | 146 | 155 | 219 | 299 | 316 | 323 | 356 | 406 | 365 | 380 | 415 | 427 |
Below is a detailed analysis of the balance sheet data for AksharChem (India) Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 8.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 8.00 Cr..
- For Reserves, as of Sep 2025, the value is 254.00 Cr.. The value appears to be declining and may need further review. It has decreased from 256.00 Cr. (Mar 2025) to 254.00 Cr., marking a decrease of 2.00 Cr..
- For Borrowings, as of Sep 2025, the value is 75.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 67.00 Cr. (Mar 2025) to 75.00 Cr., marking an increase of 8.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 90.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 85.00 Cr. (Mar 2025) to 90.00 Cr., marking an increase of 5.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 427.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 415.00 Cr. (Mar 2025) to 427.00 Cr., marking an increase of 12.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 269.00 Cr.. The value appears strong and on an upward trend. It has increased from 232.00 Cr. (Mar 2025) to 269.00 Cr., marking an increase of 37.00 Cr..
- For CWIP, as of Sep 2025, the value is 15.00 Cr.. The value appears to be declining and may need further review. It has decreased from 45.00 Cr. (Mar 2025) to 15.00 Cr., marking a decrease of 30.00 Cr..
- For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Assets, as of Sep 2025, the value is 144.00 Cr.. The value appears strong and on an upward trend. It has increased from 139.00 Cr. (Mar 2025) to 144.00 Cr., marking an increase of 5.00 Cr..
- For Total Assets, as of Sep 2025, the value is 427.00 Cr.. The value appears strong and on an upward trend. It has increased from 415.00 Cr. (Mar 2025) to 427.00 Cr., marking an increase of 12.00 Cr..
Notably, the Reserves (254.00 Cr.) exceed the Borrowings (75.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 24.00 | 3.00 | 1.00 | 46.00 | 42.00 | 22.00 | 13.00 | 9.00 | -18.00 | -10.00 | -50.00 | -42.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 34 | 38 | 44 | 20 | 38 | 43 | 42 | 42 | 51 | 39 | 57 | 43 |
| Inventory Days | 49 | 53 | 54 | 102 | 68 | 65 | 104 | 148 | 115 | 99 | 131 | 130 |
| Days Payable | 90 | 111 | 96 | 100 | 70 | 49 | 62 | 97 | 80 | 64 | 88 | 106 |
| Cash Conversion Cycle | -7 | -19 | 2 | 22 | 35 | 59 | 83 | 93 | 86 | 75 | 100 | 67 |
| Working Capital Days | 16 | 8 | 28 | 31 | 56 | 85 | 104 | 75 | 62 | 69 | 55 | 18 |
| ROCE % | 85% | 34% | 27% | 53% | 21% | 13% | 7% | 6% | 6% | 1% | -4% | 3% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 16 | Mar 15 |
|---|---|---|
| FaceValue | 10.00 | 10.00 |
| Basic EPS (Rs.) | 22.75 | 21.88 |
| Diluted EPS (Rs.) | 22.75 | 21.88 |
| Cash EPS (Rs.) | 28.55 | 27.22 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 116.24 | 97.70 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 116.24 | 97.70 |
| Revenue From Operations / Share (Rs.) | 256.85 | 273.48 |
| PBDIT / Share (Rs.) | 45.83 | 40.36 |
| PBIT / Share (Rs.) | 40.03 | 35.02 |
| PBT / Share (Rs.) | 35.45 | 30.57 |
| Net Profit / Share (Rs.) | 22.75 | 21.88 |
| NP After MI And SOA / Share (Rs.) | 22.75 | 21.88 |
| PBDIT Margin (%) | 17.84 | 14.75 |
| PBIT Margin (%) | 15.58 | 12.80 |
| PBT Margin (%) | 13.80 | 11.17 |
| Net Profit Margin (%) | 8.85 | 8.00 |
| NP After MI And SOA Margin (%) | 8.85 | 8.00 |
| Return on Networth / Equity (%) | 19.57 | 22.39 |
| Return on Capital Employeed (%) | 29.32 | 31.30 |
| Return On Assets (%) | 10.72 | 10.92 |
| Long Term Debt / Equity (X) | 0.07 | 0.02 |
| Total Debt / Equity (X) | 0.33 | 0.32 |
| Asset Turnover Ratio (%) | 1.25 | 0.00 |
| Current Ratio (X) | 1.28 | 1.08 |
| Quick Ratio (X) | 0.98 | 0.79 |
| Inventory Turnover Ratio (X) | 6.24 | 0.00 |
| Dividend Payout Ratio (NP) (%) | 15.38 | 15.99 |
| Dividend Payout Ratio (CP) (%) | 12.25 | 12.85 |
| Earning Retention Ratio (%) | 84.62 | 84.01 |
| Cash Earning Retention Ratio (%) | 87.75 | 87.15 |
| Interest Coverage Ratio (X) | 10.02 | 9.07 |
| Interest Coverage Ratio (Post Tax) (X) | 5.97 | 5.56 |
| Enterprise Value (Cr.) | 147.77 | 137.44 |
| EV / Net Operating Revenue (X) | 0.78 | 0.68 |
| EV / EBITDA (X) | 4.41 | 4.66 |
| MarketCap / Net Operating Revenue (X) | 0.63 | 0.57 |
| Retention Ratios (%) | 84.61 | 84.00 |
| Price / BV (X) | 1.41 | 1.62 |
| Price / Net Operating Revenue (X) | 0.63 | 0.57 |
| EarningsYield | 0.13 | 0.13 |
After reviewing the key financial ratios for AksharChem (India) Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 16, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 15) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 16, the value is 22.75. This value is within the healthy range. It has increased from 21.88 (Mar 15) to 22.75, marking an increase of 0.87.
- For Diluted EPS (Rs.), as of Mar 16, the value is 22.75. This value is within the healthy range. It has increased from 21.88 (Mar 15) to 22.75, marking an increase of 0.87.
- For Cash EPS (Rs.), as of Mar 16, the value is 28.55. This value is within the healthy range. It has increased from 27.22 (Mar 15) to 28.55, marking an increase of 1.33.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 16, the value is 116.24. It has increased from 97.70 (Mar 15) to 116.24, marking an increase of 18.54.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 16, the value is 116.24. It has increased from 97.70 (Mar 15) to 116.24, marking an increase of 18.54.
- For Revenue From Operations / Share (Rs.), as of Mar 16, the value is 256.85. It has decreased from 273.48 (Mar 15) to 256.85, marking a decrease of 16.63.
- For PBDIT / Share (Rs.), as of Mar 16, the value is 45.83. This value is within the healthy range. It has increased from 40.36 (Mar 15) to 45.83, marking an increase of 5.47.
- For PBIT / Share (Rs.), as of Mar 16, the value is 40.03. This value is within the healthy range. It has increased from 35.02 (Mar 15) to 40.03, marking an increase of 5.01.
- For PBT / Share (Rs.), as of Mar 16, the value is 35.45. This value is within the healthy range. It has increased from 30.57 (Mar 15) to 35.45, marking an increase of 4.88.
- For Net Profit / Share (Rs.), as of Mar 16, the value is 22.75. This value is within the healthy range. It has increased from 21.88 (Mar 15) to 22.75, marking an increase of 0.87.
- For NP After MI And SOA / Share (Rs.), as of Mar 16, the value is 22.75. This value is within the healthy range. It has increased from 21.88 (Mar 15) to 22.75, marking an increase of 0.87.
- For PBDIT Margin (%), as of Mar 16, the value is 17.84. This value is within the healthy range. It has increased from 14.75 (Mar 15) to 17.84, marking an increase of 3.09.
- For PBIT Margin (%), as of Mar 16, the value is 15.58. This value is within the healthy range. It has increased from 12.80 (Mar 15) to 15.58, marking an increase of 2.78.
- For PBT Margin (%), as of Mar 16, the value is 13.80. This value is within the healthy range. It has increased from 11.17 (Mar 15) to 13.80, marking an increase of 2.63.
- For Net Profit Margin (%), as of Mar 16, the value is 8.85. This value is within the healthy range. It has increased from 8.00 (Mar 15) to 8.85, marking an increase of 0.85.
- For NP After MI And SOA Margin (%), as of Mar 16, the value is 8.85. This value is within the healthy range. It has increased from 8.00 (Mar 15) to 8.85, marking an increase of 0.85.
- For Return on Networth / Equity (%), as of Mar 16, the value is 19.57. This value is within the healthy range. It has decreased from 22.39 (Mar 15) to 19.57, marking a decrease of 2.82.
- For Return on Capital Employeed (%), as of Mar 16, the value is 29.32. This value is within the healthy range. It has decreased from 31.30 (Mar 15) to 29.32, marking a decrease of 1.98.
- For Return On Assets (%), as of Mar 16, the value is 10.72. This value is within the healthy range. It has decreased from 10.92 (Mar 15) to 10.72, marking a decrease of 0.20.
- For Long Term Debt / Equity (X), as of Mar 16, the value is 0.07. This value is below the healthy minimum of 0.2. It has increased from 0.02 (Mar 15) to 0.07, marking an increase of 0.05.
- For Total Debt / Equity (X), as of Mar 16, the value is 0.33. This value is within the healthy range. It has increased from 0.32 (Mar 15) to 0.33, marking an increase of 0.01.
- For Asset Turnover Ratio (%), as of Mar 16, the value is 1.25. It has increased from 0.00 (Mar 15) to 1.25, marking an increase of 1.25.
- For Current Ratio (X), as of Mar 16, the value is 1.28. This value is below the healthy minimum of 1.5. It has increased from 1.08 (Mar 15) to 1.28, marking an increase of 0.20.
- For Quick Ratio (X), as of Mar 16, the value is 0.98. This value is below the healthy minimum of 1. It has increased from 0.79 (Mar 15) to 0.98, marking an increase of 0.19.
- For Inventory Turnover Ratio (X), as of Mar 16, the value is 6.24. This value is within the healthy range. It has increased from 0.00 (Mar 15) to 6.24, marking an increase of 6.24.
- For Dividend Payout Ratio (NP) (%), as of Mar 16, the value is 15.38. This value is below the healthy minimum of 20. It has decreased from 15.99 (Mar 15) to 15.38, marking a decrease of 0.61.
- For Dividend Payout Ratio (CP) (%), as of Mar 16, the value is 12.25. This value is below the healthy minimum of 20. It has decreased from 12.85 (Mar 15) to 12.25, marking a decrease of 0.60.
- For Earning Retention Ratio (%), as of Mar 16, the value is 84.62. This value exceeds the healthy maximum of 70. It has increased from 84.01 (Mar 15) to 84.62, marking an increase of 0.61.
- For Cash Earning Retention Ratio (%), as of Mar 16, the value is 87.75. This value exceeds the healthy maximum of 70. It has increased from 87.15 (Mar 15) to 87.75, marking an increase of 0.60.
- For Interest Coverage Ratio (X), as of Mar 16, the value is 10.02. This value is within the healthy range. It has increased from 9.07 (Mar 15) to 10.02, marking an increase of 0.95.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 16, the value is 5.97. This value is within the healthy range. It has increased from 5.56 (Mar 15) to 5.97, marking an increase of 0.41.
- For Enterprise Value (Cr.), as of Mar 16, the value is 147.77. It has increased from 137.44 (Mar 15) to 147.77, marking an increase of 10.33.
- For EV / Net Operating Revenue (X), as of Mar 16, the value is 0.78. This value is below the healthy minimum of 1. It has increased from 0.68 (Mar 15) to 0.78, marking an increase of 0.10.
- For EV / EBITDA (X), as of Mar 16, the value is 4.41. This value is below the healthy minimum of 5. It has decreased from 4.66 (Mar 15) to 4.41, marking a decrease of 0.25.
- For MarketCap / Net Operating Revenue (X), as of Mar 16, the value is 0.63. This value is below the healthy minimum of 1. It has increased from 0.57 (Mar 15) to 0.63, marking an increase of 0.06.
- For Retention Ratios (%), as of Mar 16, the value is 84.61. This value exceeds the healthy maximum of 70. It has increased from 84.00 (Mar 15) to 84.61, marking an increase of 0.61.
- For Price / BV (X), as of Mar 16, the value is 1.41. This value is within the healthy range. It has decreased from 1.62 (Mar 15) to 1.41, marking a decrease of 0.21.
- For Price / Net Operating Revenue (X), as of Mar 16, the value is 0.63. This value is below the healthy minimum of 1. It has increased from 0.57 (Mar 15) to 0.63, marking an increase of 0.06.
- For EarningsYield, as of Mar 16, the value is 0.13. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 15) which recorded 0.13.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in AksharChem (India) Ltd:
- Net Profit Margin: 8.85%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 29.32% (Industry Average ROCE: 11%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 19.57% (Industry Average ROE: 9.1%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 5.97
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.98
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 799 (Industry average Stock P/E: 86.99)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.33
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 8.85%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Dyes & Pigments | Akshar House, Mehsana Gujarat 382715 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mrs. Paru M Jaykrishna | Chairperson & Managing Director |
| Mr. Munjal M Jaykrishna | Joint Managing Director & CEO |
| Mr. Ashok D Barot | Executive Director |
| Mr. Jigar Mukesh Patel | Independent Director |
| Ms. Maitri K Mehta | Independent Director |
| Mr. Nirav K Shah | Independent Director |
| Mr. Sameer S Sinha | Independent Director |
| Mr. Keyur D Gandhi | Independent Director |
| Mr. Sachin M Jaykrishna | Whole Time Director |
FAQ
What is the intrinsic value of AksharChem (India) Ltd?
AksharChem (India) Ltd's intrinsic value (as of 20 January 2026) is ₹2490.80 which is 1016.95% higher the current market price of ₹223.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's ₹176 Cr. market cap, FY2025-2026 high/low of ₹331/193, reserves of ₹254 Cr, and liabilities of ₹427 Cr.
What is the Market Cap of AksharChem (India) Ltd?
The Market Cap of AksharChem (India) Ltd is 176 Cr..
What is the current Stock Price of AksharChem (India) Ltd as on 20 January 2026?
The current stock price of AksharChem (India) Ltd as on 20 January 2026 is ₹223.
What is the High / Low of AksharChem (India) Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of AksharChem (India) Ltd stocks is ₹331/193.
What is the Stock P/E of AksharChem (India) Ltd?
The Stock P/E of AksharChem (India) Ltd is 799.
What is the Book Value of AksharChem (India) Ltd?
The Book Value of AksharChem (India) Ltd is 326.
What is the Dividend Yield of AksharChem (India) Ltd?
The Dividend Yield of AksharChem (India) Ltd is 0.34 %.
What is the ROCE of AksharChem (India) Ltd?
The ROCE of AksharChem (India) Ltd is 3.46 %.
What is the ROE of AksharChem (India) Ltd?
The ROE of AksharChem (India) Ltd is 1.82 %.
What is the Face Value of AksharChem (India) Ltd?
The Face Value of AksharChem (India) Ltd is 10.0.